Pacific Biosciences of California PACB Payments made in conjunction with convertible notes exchange
Payments made in conjunction with convertible notes exchange at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept pacb:PaymentsInConjunctionWithNotesExchange.
The official record: Pacific Biosciences of California’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's payments made in conjunction with convertible notes exchange.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's payments made in conjunction with convertible notes exchange?
- Pacific Biosciences of California (PACB) reported payments made in conjunction with convertible notes exchange of $0 in Q4 2025.
- How has Pacific Biosciences of California's payments made in conjunction with convertible notes exchange changed year-over-year?
- Pacific Biosciences of California's payments made in conjunction with convertible notes exchange decreased by 100.0% year-over-year, from $12.55M to $0.
- What does payments made in conjunction with convertible notes exchange mean?
- Represents cash outflows associated with the exchange or refinancing of convertible debt instruments. This metric is critical for understanding the cash cost of managing long-term debt obligations and potential dilution events.